Literature DB >> 2594886

How does gender influence age at first hospitalization for schizophrenia? A transnational case register study.

H Häfner1, A Riecher, K Maurer, W Löffler, P Munk-Jørgensen, E Strömgren.   

Abstract

Numerous studies have reported a lower mean age at first hospitalization for schizophrenia in males than in females. For this finding not only a gender difference in age at first onset of schizophrenia, but also other factors can be responsible. With the aim of providing a comprehensive analysis of gender differences in onset, symptomatology and course of schizophrenia, we started by testing the hypothesis postulating a gender difference in mean age at first hospitalization. By using the Danish and the Mannheim psychiatric case registers we analysed all hospital admissions for schizophrenia and related diagnoses and all previous admissions for other diagnoses of the Danish population in 1976 and those of the inhabitants of the German city of Mannheim in the period of 1978-80. Artefacts were controlled for systematically. The impact of intervening variables such as selection factors as well as the influence of gender on the ascription of a diagnosis of schizophrenia for the first time were assessed. We found a mean difference of 5 to 6 years in age at first hospitalization between males and females in both countries when a broad definition of the diagnosis was used and of 4 to 5 years when a restrictive definition was applied. The higher mean age at first hospitalization among females is not attributable to artefacts, diagnostic procedures or to any essential extent to gender differences in help-seeking behaviour or occupational status. When a distinction was made between 'single' and 'married', the significant difference in age at first hospitalization between the sexes disappeared in singles. With case register data and without knowing the chronological order of marriage and onset of the disease, it remains an open question whether this finding can be explained by purely correlative associations between sex, marital status and age of onset or by causal effects.

Entities:  

Mesh:

Year:  1989        PMID: 2594886     DOI: 10.1017/s0033291700005626

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  40 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

2.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

3.  Gene expression in superior temporal cortex of schizophrenia patients.

Authors:  C Sellmann; L Villarín Pildaín; A Schmitt; F Leonardi-Essmann; P F Durrenberger; R Spanagel; T Arzberger; H Kretzschmar; M Zink; O Gruber; M Herrera-Marschitz; R Reynolds; P Falkai; P J Gebicke-Haerter; F Matthäus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-28       Impact factor: 5.270

4.  Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial.

Authors:  Mark Weiser; Linda Levi; Daisy Zamora; Anat Biegon; John Paul SanGiovanni; Michael Davidson; Shimon Burshtein; Ilan Gonen; Paull Radu; Kristina Slobozean Pavalache; Igor Nastas; Rina Hemi; Timothy Ryan; John M Davis
Journal:  JAMA Psychiatry       Date:  2019-10-01       Impact factor: 21.596

5.  The role of estrogen in schizophrenia.

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

6.  Forty-two-years later: the outcome of childhood-onset schizophrenia.

Authors:  H Remschmidt; M Martin; C Fleischhaker; F M Theisen; K Hennighausen; C Gutenbrunner; E Schulz
Journal:  J Neural Transm (Vienna)       Date:  2006-08-10       Impact factor: 3.575

7.  The impact of gender and age at onset on the familial aggregation of schizophrenia.

Authors:  W Maier; D Lichtermann; J Minges; R Heun; J Hallmayer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

8.  First-contact rate for schizophrenia in community psychiatric care. Consideration of the oestrogen hypothesis.

Authors:  R K Salokangas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 9.  Schizophrenia and oestrogens--is there an association?

Authors:  A Riecher-Rössler; H Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

10.  Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients.

Authors:  Ann E Maloney; Linmarie Sikich
Journal:  Neuropsychiatr Dis Treat       Date:  2010-11-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.